PMID: 15247626Jul 13, 2004Paper

Functional responses of human beta1 adrenoceptors with defined haplotypes for the common 389R>G and 49S>G polymorphisms

Pharmacogenetics
A J SandilandsK M O'Shaughnessy

Abstract

The human beta1-adrenoceptor (beta1-AR) is an important therapeutic target for cardiovascular diseases and has two common functional polymorphisms (49S>G and 389R>G). These polymorphisms have only been studied in isolation, however, and not in the context of the four haplotypes (SR, SG, GR and GG) that exist in native beta1-ARs. To address this, the function of each of the receptor haplotypes was studied in HEK 293 cells stably transfected with appropriately modified human beta1-adrenoceptor cDNA sequence. The affinity for the beta-adrenoceptor ligand, [125I]-cyanopindolol, was not significantly different across the haplotypes, but a high affinity state for the beta1-AR could only be demonstrated for receptors carrying the 389R substitution. Both basal (GR 36.3 +/- 2.9* vs. SR 16.5 0 +/- 3.6 and GG 31.7 +/- 1.4* vs. SG 15.6 +/- 1.5 pmol/mg protein; *P < 0.001) and maximal (GR 163 +/- 7.6 vs. SR 124 +/- 8.1* and GG 75.0 +/- 1.0 vs. SG 52.4 +/- 1.1* pmol/mg protein; *P < 0.001) isoprenaline-evoked cAMP production was significantly affected by both substitutions. Incubation with isoprenaline (10 microm for 30 min or 20 h) caused increased down-regulation of beta1-ARs in cells expressing GG and GR haplotypes (at 20 h percentage fal...Continue Reading

References

Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·T FrielleB K Kobilka
Jul 22, 1982·The New England Journal of Medicine·M R BristowE B Stinson
Apr 23, 1999·The Journal of Biological Chemistry·D A MasonS B Liggett
May 4, 2000·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·S PodlowskiG Wallukat
Dec 26, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·M RydénP Arner
Jan 16, 2002·Journal of Cardiovascular Pharmacology·Deborah A RathzStephen B Liggett
Feb 21, 2002·American Journal of Human Genetics·Koustubh RanadeNeil Risch
Jan 24, 2003·Annual Review of Pharmacology and Toxicology·Kersten M SmallStephen B Liggett

❮ Previous
Next ❯

Citations

Apr 26, 2006·The Pharmacogenomics Journal·M R G Taylor
Sep 12, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Maple M FungUNKNOWN AASK Co-Investigators
Nov 27, 2008·Journal of Cardiovascular Pharmacology·Koratagere Nagaraju Mahesh KumarChandrasekaran Adithan
May 24, 2011·Journal of Obesity·Kazuko Masuo, Gavin W Lambert
Oct 29, 2010·International Journal of Hypertension·Kazuko Masuo
Aug 15, 2012·Journal of Cardiothoracic and Vascular Anesthesia·Miklos D KertaiMihai V Podgoreanu
Aug 27, 2005·British Journal of Clinical Pharmacology·A J Sandilands, K M O'Shaughnessy
May 9, 2009·British Journal of Pharmacology·Kirsten Leineweber, Gerd Heusch
Jul 11, 2008·Clinical Pharmacology and Therapeutics·M A PacanowskiUNKNOWN INVEST Investigators
Dec 26, 2007·European Journal of Heart Failure·Amal MuthumalaSteve E Humphries
May 16, 2008·Journal of Cardiovascular Electrophysiology·Cem UlucanCan Hasdemir
Mar 21, 2008·Fundamental & Clinical Pharmacology·Otto-Erich Brodde
Dec 6, 2005·Journal of the American College of Cardiology·Heike BruckOtto-Erich Brodde
Sep 27, 2016·PloS One·Mélanie MétrichUNKNOWN Swiss Transplant Cohort Study
Apr 14, 2006·Journal of Pharmacological Sciences·Otto-Erich BroddeKirsten Leineweber
Jun 15, 2014·Pharmacological Reviews·Andrea Ahles, Stefan Engelhardt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.